TUESDAY, May 2, 2023 (HealthDay News) — The U.S. Food and Drug Administration is once again warning consumers to avoid muscle-building “supplements” that are anything but a safe alternative to steroids. In an advisory sent out last week, the agency said it continues to receive reports of serious side effectsContinue Reading

TUESDAY, April 4, 2023 (HealthDay News) — Over the last decade, more and more Americans with early-stage prostate cancer have put off radiation and surgery, the standard treatment options, new research indicates. Instead, many U.S. men with low- or intermediate-risk prostate cancer have embraced “active surveillance,” in which their diseaseContinue Reading

TUESDAY, March 21, 2023 (HealthDay News) — An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment. The drug’s maker, Novartis Pharmaceuticals Corp., has said it can’t keep up with demand for the medication, known as Pluvicto.Continue Reading

THURSDAY, March 2, 2023 (HealthDay News) — Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports. The procedure, called prostate artery embolization (PAE), dramatically improved urinary symptoms in patients without having any effectContinue Reading